Interleukin-11 for treatment of hepatitis C-associated ITP

Acta Haematologica

Volumn 119, Issue 2, 2008, Pages 126-132

  Fontana, Vincenzo ^a   Dudkiewicz, Pamela ^a   Jy, Wenche ^a   Horstman, Larry ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C; Immune thrombocytopenic purpura; Interleukin 11

Indexed keywords

RECOMBINANT INTERLEUKIN 11; VIRUS RNA;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; FLUID RETENTION; HEPATITIS C; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SKIN DISCOLORATION; THROMBOCYTE COUNT;

ANTIBODIES; BLOOD PLATELETS; FEMALE; HEPATITIS C; HUMANS; INTERLEUKIN-11; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RNA, VIRAL; TREATMENT OUTCOME;

EID: 42549150137     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000125192     Document Type: Article

References (18)

1. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I: Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Haematology. Blood 1996;88:3-40.
2. Jacobson Brown PM, Neuman MG: Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines. Clin Biochem 2001;34:167-171.
3. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G: HCV infection and extrahepatic manifestations. Hepatogastroenterology 2003;50:1149-1154.
4. Garcia-Suarez J, Burgaleta C, Hernanz N, Albarran F, Tobaruela P, Alvarez-Mon M: HCV-associated thrombocytopenia: clinical characteristics and platelet response alter recombinant alpha2b-interferon therapy. Br J Haematol 2000;110:98-103.
5. Rajan SK, Espina BM, Liebman HA: Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol 2005;129:818-824.
6. Liebman HA, Stasi R: Secondary immune thrombocytopenic purpura. Curr Opin Hematol 2007;14:557-573.
7. Du X, Williams DA: Interleukin-11: review of molecular, cell biology, and clinical use. Blood 1997;89:3897-3908.
8. Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ: Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 1999;13:1307-1315.
9. Curti A, Ratta M, Corinti S, Girolomoni G, Ricci F, Tazzari P, Siena M, Grande A, Fogli M, Tura S, Lemoli RM: Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood 2001;97:2758-2763.
10. Trepicchio WL, Ozawa M, Walters IB, Kikuchi T, Gilleadudeau P, Bliss JL, Schwertschlag U, Dorner AJ, Krueger JG: Interleukin-11 therapy selectively downregulates type I cytokines proinflammatory pathways in psoriasis lesions. J Clin Invest 1999;104:1527-1537.
11. Peterson RL, Wang L, Albert L, Marchese E, Erickson J, Wong A, Mounts WM, Hayes L, Bouchard P, Keith J, Dorner AJ: Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease. Pharmacogenomics J 2002;2:383-399.
12. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC Jr, Brinson YS, Bungard D, Ferrara JL: Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogenic bone marrow transplantation. J Clin Invest 1998;102:115-123.
13. Macchi L, Clofent-Sanchez G, Marit G, Bihour C, Durrieu-Jais C, Besse P, Norden P, Nurden AT: A method for characterizing platelet-associated antibodies: its application to the study of idiopathic thrombocytopenic purpura and the detection of platelet-bound c7E3. Thromb Hemostasis 1996;76:1020-1029.
14. Ghalib R, Levine C, Hassan M, McClelland T, Goss J, Stribling R, Seu P, Patt YZ: Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis. Hepatology 2003;37:1165-1171.
15. Lawitz EJ, Hepburn MJ, Casey TJ: A pilot study of interleukin-11 in subjects with chronic hepatitis and advanced liver disease nonresponsive to antiviral therapy. Am J Gastroenterol 2004;99:2359-2364.
16. Bussel JB, Mukherjee R, Stone AJ: A pilot study of rhuIL-11 treatment of refractory ITP. Am J Hematol 2001;66:172-177.
17. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E: Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2002;97:2040-2045.
18. Christodoulou D, Christo L, Zervou E, Katsanos K, Kitsanou M, Tsianos EV: Antiplatelet antibodies in patients with chronic viral hepatitis received interferon-alpha. Hepatogastroenterology 2007;54:1761-1765.